---
figid: PMC4750418__fasebj278416f10
figlink: /pmc/articles/PMC4750418/figure/F10/
number: Figure 10
caption: The model proposed in this study. PDGF is known to activate PI3K/AKT and
  RAF/MEK/ERK pathways. ERK phosphorylates cPLA2α, which leads to activation of cPLA2α
  and production of PGE2. Binding of PGE2 to EP4 receptor activates the PI3K/AKT/FOXO1
  pathway, ultimately enhancing G1 progression through FOXO1 nuclear export and modulating
  cyclin D1 and p27Kip1 expression. Moreover, the RAF/MEK/ERK signaling pathway regulates
  cyclin D1 and p27Kip1 expression through cPLA2α-independent mechanisms. MEK (PD98059),
  cPLA2α (pyrrophenone), PI3K (Ly294002), and FOXO1 (AS1842856) inhibitors were used
  in this study to elucidate the role of each pathway in the regulation of the G1
  progression. C, cytoplasm; N, nucleus.
pmcid: PMC4750418
papertitle: Cytosolic phospholipase A2α regulates G1 progression through modulating
  FOXO1 activity.
reftext: Said Movahedi Naini, et al. FASEB J. 2016 Mar;30(3):1155-1170.
pmc_ranked_result_index: '75248'
pathway_score: 0.9651763
filename: fasebj278416f10.jpg
figtitle: Model proposed in this study
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4750418__fasebj278416f10.html
  '@type': Dataset
  description: The model proposed in this study. PDGF is known to activate PI3K/AKT
    and RAF/MEK/ERK pathways. ERK phosphorylates cPLA2α, which leads to activation
    of cPLA2α and production of PGE2. Binding of PGE2 to EP4 receptor activates the
    PI3K/AKT/FOXO1 pathway, ultimately enhancing G1 progression through FOXO1 nuclear
    export and modulating cyclin D1 and p27Kip1 expression. Moreover, the RAF/MEK/ERK
    signaling pathway regulates cyclin D1 and p27Kip1 expression through cPLA2α-independent
    mechanisms. MEK (PD98059), cPLA2α (pyrrophenone), PI3K (Ly294002), and FOXO1 (AS1842856)
    inhibitors were used in this study to elucidate the role of each pathway in the
    regulation of the G1 progression. C, cytoplasm; N, nucleus.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDKN1B
  - PDGFC
  - PTGER4
  - AKT2
  - PIK3CA
  - MAP2K1
  - HRAS
  - KRAS
  - AKT1
  - AKT3
  - PDGFB
  - PIK3R5
  - PDGFD
  - FOXO1
  - PIK3R6
  - PIK3R3
  - MAPK1
  - MAPK3
  - MAP2K2
  - PIK3CD
  - PIK3CG
  - CCND1
  - PDGFA
  - NRAS
  - PIK3R4
  - PIK3CB
  - ELy294002
  - PD98059
  - Pyrrophenone
  - L-161982
  - PGE2
  - Cancer
genes:
- word: p27Kip1.
  symbol: P27KIP1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1B
  entrez: '1027'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: EP4
  symbol: EP4
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER4
  entrez: '5734'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: p-FOXO1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: -cyclinD1-
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals:
- word: ELy294002
  source: MESH
  identifier: C085911
- word: PD98059
  source: MESH
  identifier: C093973
- word: Pyrrophenone
  source: MESH
  identifier: C455981
- word: L-161982
  source: MESH
  identifier: C508711
- word: PGE2
  source: MESH
  identifier: D015232
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
